Kalindi Agro Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 29-06-2024
- Paid Up Capital ₹ 2.32 Cr
as on 29-06-2024
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.50 Cr
as on 29-06-2024
- Revenue -37.10%
(FY 2022)
- Profit -37.40%
(FY 2022)
- Ebitda -60.27%
(FY 2022)
- Net Worth 58.96%
(FY 2022)
- Total Assets 0.52%
(FY 2022)
About Kalindi Agro Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.32 Cr.
The company has closed loans amounting to ₹1.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sandeep Jain, Abhishek Mundhra, and Depak Jain serve as directors at the Company.
- CIN/LLPIN
U74899DL1993PLC055876
- Company No.
055876
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Nov 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kalindi Agro Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Jain  | Director | 01-Nov-1993 | Current |
| Abhishek Mundhra | Director | 27-Sep-2017 | Current |
| Depak Jain | Director | 22-Sep-2000 | Current |
Financial Performance of Kalindi Agro Biotech.
Kalindi Agro Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 37.1% decrease. The company also saw a substantial fall in profitability, with a 37.4% decrease in profit. The company's net worth Soared by an impressive increase of 58.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kalindi Agro Biotech?
In 2020, Kalindi Agro Biotech had a promoter holding of 44.01% and a public holding of 55.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Geo Miller & Company Private Limited (Trans.W.B.To Delhi )Active 95 years 8 monthsAbhishek Mundhra is a mutual person
- Simplex Envirosciences And Infradevelopment Private LimitedActive 22 years 9 months
Abhishek Mundhra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 14 Sep 1996 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Kalindi Agro Biotech?
Unlock and access historical data on people associated with Kalindi Agro Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kalindi Agro Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalindi Agro Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
